Drug reference
metformin-vildagliptin
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Peptide analogues)
Mechanism of action
Metformin acts primarily by decreasing endogenous hepatic glucose production. Vildagliptin Vildagliptin acts primarily by inhibiting DPP-4, the enzyme responsible for the degradation of the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
Common side effects
- Tremor
- Dizziness
- Headache
- Fatigue
- Nausea
- Hypoglycaemia
Related conditions
Frequently asked questions
What drug class is metformin-vildagliptin?
metformin-vildagliptin belongs to: Endocrine.
How does metformin-vildagliptin work?
Metformin acts primarily by decreasing endogenous hepatic glucose production. Vildagliptin Vildagliptin acts primarily by inhibiting DPP-4, the enzyme responsible for the degradation of the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
What are the common side effects of metformin-vildagliptin?
Tremor, Dizziness, Headache, Fatigue, Nausea, Hypoglycaemia
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.